Cover of Generic Drug Product Development: Bioequivalence Issues by Kanfer, Isadore, Shargel, Leon, ISBN 9780849377846
Chemistry

Generic Drug Product Development: Bioequivalence Issues

Contributor(s): Author , Author Format: Hardback

Hardback Β· ISBN 9780849377846

β‚Ή33,185

Inclusive of GST and other taxes

100% Quality Assurance
No Account Creation Required
Fast Delivery
Secured Transactions

Arriving at your doorstep in 10-15 days

Our logisitcs team will make sure everyitem is delivered safely

Key Specifications

ISBN 9780849377846
Publisher CRC Press
Publication date November 2007
Language English
MRP Β£210.00 GBP
Page count 286
Item weight 122 g

The assessment of bioequivalence is an important process whereby the bioavailability of a generic drug product is compared with its brand-name counterpart. Generic pharmaceutical products must be approved as therapeutic equivalents to the brand name alternative in order to be interchangeable. The demonstration of bioequivalence is an important component of therapeutic equivalence. Bioequivalence studies are very expensive, time consuming and always have the possibility of failure. The objective of this textbook is to describe some of those specific bioequivalence issues which need to be considered for the design and conduct of bioequivalence studies. By exploring scientific, legal, and international regulatory challenges, Generic Drug Development, discusses the use of alternative approaches to the measurement of plasma drug concentrations for the demonstration of bioequivalence, and covers bioequivalence procedures for drug products that are not easily assessed - based upon the physical and chemical properties of the active drug and the nature of the drug product.